In the 2026 pharmaceutical and export landscape, the combination of Hydroquinone, Tretinoin, and Mometasone Furoate is known as Triple Combination (TC) Cream.
As a pharmacist and manufacturer at Healthy Life Pharma, I must be direct: This is a highly potent, prescription-only medical treatment. While it is technically “safe” for the face when used under strict clinical supervision for short durations, it is one of the most misused products in the global dermatology market.
1. The Technical “Triple Action” Mechanism
Each API in this formulation serves a specific, aggressive purpose for treating severe melasma or hyperpigmentation:
| Ingredient | Role | Technical Action |
| Hydroquinone (2-4%) | Depigmenting Agent | Inhibits tyrosinase, stopping the production of new melanin. |
| Tretinoin (0.025-0.05%) | Retinoid | Increases $keratinocyte$ turnover, “shuttling” existing pigment to the surface to be shed. |
| Mometasone (0.1%) | Potent Steroid | Suppresses the irritation caused by Tretinoin and reduces the inflammatory component of melasma. |
2. The “Hard Rules” for Facial Safety
If you are listing this on your Healthy Inc marketplace, you must include these 2026 safety guardrails to protect your buyers and their customers:
The 8-Week Limit: Critical Warning: This cream is not a daily moisturizer. It should technically only be used for 6 to 8 weeks. Long-term use of Mometasone (a potent Class III/IV steroid) on the face causes irreversible skin thinning, visible blood vessels (telangiectasia), and steroid-induced acne.
Night-Only Application: Tretinoin and Hydroquinone are highly unstable in sunlight and can cause a severe “chemical burn” if exposed to UV rays. It must only be applied at night.
Sunscreen Mandate: Using this cream without a broad-spectrum SPF 50+ during the day is dangerous. It can lead to paradoxical darkening or severe photosensitivity.
The “Peeling” Phase: Users must be warned that redness and peeling are expected. However, if the skin becomes raw or “weepy,” they must stop immediately to avoid permanent scarring.
3. The Risk of Exogenous Ochronosis
Because this cream contains Hydroquinone, prolonged facial use (beyond 3–4 months) carries the risk of Exogenous Ochronosis—a permanent blue-black discolouration. In your digital dossiers, this must be highlighted as a risk of misuse.